NCT02072317

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer Stage II Randomized Controlled Clinical Studies

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: Fudan University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate and compare safety and effectiveness of Chemotherapy in Paclitaxel plus raltitrexed plug compare with taxol second-line treatment for advanced gastric cancer

Detailed description

from the first cycle of treatment (day one) to two month after the last cycle

Conditions

• Advanced Gastric Cancer

Interventions

Type	Name	Description
DRUG	taxel plus raltitrexed	taxol 135 mg/m2, raltitrexed 3 mg/m2 ivgtt d1, every three weeks for a cycle
DRUG	taxol	taxol 135 mg/m2, every three weeks for a cycle

Timeline

• Start date: 2013-11-01
• Primary completion: 2016-03-01
• Completion: 2016-03-01
• First posted: 2014-02-26
• Last updated: 2014-02-26

Locations

1 site across 1 country: China